Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable on Friday 8 July 2011 has been set at NZ$2.6341 per share.
Read more
Fisher & Paykel Healthcare Corporation Limited is pleased to offer its ordinary shareholders residing in New Zealand and Australia the option to participate in a Dividend Reinvestment Plan (DRP).
Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable...
Fisher & Paykel Healthcare Corporation Limited advises that the strike price for the dividend reinvestment plan operating in respect of the dividend payable on Friday 19 December 2014 has been set at NZ$6.0532 per share.
Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) advises that the strike price for the dividend reinvestment plan (DRP) operating in respect of the dividend payable on Friday 10 July 2015 has been set at NZ$6.9484 per share.
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment
The AIRVO 2 family enables the transition of Optiflow therapy across critical, non-critical areas of the hospital and into the home.
Humidification for patients using a mask at home
Humidification for patients with a tracheostomy at home
A flow range of 2 to 60 L/min allows for use across the care continuum - from the most acute hospital environment to the home
With Optiflow you can independently titrate flow and FiO2 according to your patient's needs
Introducing F&P Evora™ Full, our new compact full face CPAP mask. Evora Full is minimal contact with full performance featuring our next generation of Dynamic Support Technology™
The adaptable, reliable and robust humidification system. Use with Evaqua™ 2 circuit technology to minimize condensate
Updates and support for healthcare professionals
Join our global team. View and apply for jobs with us.
Get in touch with our team, find a distributor or send an enquire.
We value your privacy. Our websites and applications use cookies to function properly and securely.